Omada Health (NASDAQ: OMDA) Stock Competitors & Peer Comparison
See OMDA's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Healthcare Information Services Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for OMDA and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| OMDA | $23.69 | -2.39% | 1.4B | 338.43 | $0.07 | N/A |
| GEHCV | $56.00 | -4.08% | 25.5B | N/A | N/A | N/A |
| BTSG | $59.13 | -2.91% | 11.6B | 47.69 | $1.24 | N/A |
| BTSGU | $195.51 | -3.30% | 11.5B | 176.79 | $1.11 | N/A |
| TEM | $64.04 | -9.41% | 11.2B | -128.08 | -$0.50 | N/A |
| SGFY | $30.49 | +0.07% | 8.9B | 70.91 | $0.43 | N/A |
| HQY | $96.37 | +3.19% | 8.1B | 22.52 | $4.28 | N/A |
| TXG | $61.54 | -5.10% | 7.8B | -104.31 | -$0.59 | N/A |
| HNGE | $87.35 | -5.92% | 6.8B | 46.70 | $1.87 | N/A |
| RCM | $14.31 | N/A | 6B | -102.21 | -$0.14 | N/A |
Stock Comparison
GE HealthCare Technologies Inc. (NASDAQ: GEHCV)
OMDA vs GEHCV Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, GEHCV has a market cap of 25.5B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while GEHCV trades at $56.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas GEHCV's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to GEHCV's ROE of +0.19%. Regarding short-term risk, OMDA is less volatile compared to GEHCV. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check GEHCV's competition here
BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG)
OMDA vs BTSG Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, BTSG has a market cap of 11.6B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while BTSG trades at $59.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas BTSG's P/E ratio is 47.69. In terms of profitability, OMDA's ROE is +0.02%, compared to BTSG's ROE of +0.15%. Regarding short-term risk, OMDA is more volatile compared to BTSG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BTSG's competition here
BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ: BTSGU)
OMDA vs BTSGU Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, BTSGU has a market cap of 11.5B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while BTSGU trades at $195.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas BTSGU's P/E ratio is 176.79. In terms of profitability, OMDA's ROE is +0.02%, compared to BTSGU's ROE of +0.15%. Regarding short-term risk, OMDA is more volatile compared to BTSGU. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BTSGU's competition here
Tempus AI, Inc. (NASDAQ: TEM)
OMDA vs TEM Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, TEM has a market cap of 11.2B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while TEM trades at $64.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas TEM's P/E ratio is -128.08. In terms of profitability, OMDA's ROE is +0.02%, compared to TEM's ROE of -0.55%. Regarding short-term risk, OMDA is less volatile compared to TEM. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check TEM's competition here
Signify Health, Inc. (NYSE: SGFY)
OMDA vs SGFY Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SGFY has a market cap of 8.9B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SGFY trades at $30.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SGFY's P/E ratio is 70.91. In terms of profitability, OMDA's ROE is +0.02%, compared to SGFY's ROE of -0.15%. Regarding short-term risk, OMDA is more volatile compared to SGFY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SGFY's competition here
HealthEquity, Inc. (NASDAQ: HQY)
OMDA vs HQY Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, HQY has a market cap of 8.1B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while HQY trades at $96.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas HQY's P/E ratio is 22.52. In terms of profitability, OMDA's ROE is +0.02%, compared to HQY's ROE of +0.11%. Regarding short-term risk, OMDA is less volatile compared to HQY. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check HQY's competition here
10x Genomics, Inc. (NASDAQ: TXG)
OMDA vs TXG Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, TXG has a market cap of 7.8B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while TXG trades at $61.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas TXG's P/E ratio is -104.31. In terms of profitability, OMDA's ROE is +0.02%, compared to TXG's ROE of -0.09%. Regarding short-term risk, OMDA is less volatile compared to TXG. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check TXG's competition here
Hinge Health, Inc. (NYSE: HNGE)
OMDA vs HNGE Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, HNGE has a market cap of 6.8B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while HNGE trades at $87.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas HNGE's P/E ratio is 46.70. In terms of profitability, OMDA's ROE is +0.02%, compared to HNGE's ROE of +0.30%. Regarding short-term risk, OMDA is less volatile compared to HNGE. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check HNGE's competition here
R1 RCM Inc. (NASDAQ: RCM)
OMDA vs RCM Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, RCM has a market cap of 6B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while RCM trades at $14.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas RCM's P/E ratio is -102.21. In terms of profitability, OMDA's ROE is +0.02%, compared to RCM's ROE of +0.00%. Regarding short-term risk, OMDA is more volatile compared to RCM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check RCM's competition here
Waystar Holding Corp. (NASDAQ: WAY)
OMDA vs WAY Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, WAY has a market cap of 5B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while WAY trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas WAY's P/E ratio is 17.38. In terms of profitability, OMDA's ROE is +0.02%, compared to WAY's ROE of +0.04%. Regarding short-term risk, OMDA is less volatile compared to WAY. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check WAY's competition here
Doximity, Inc. (NYSE: DOCS)
OMDA vs DOCS Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, DOCS has a market cap of 5B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while DOCS trades at $26.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas DOCS's P/E ratio is 17.47. In terms of profitability, OMDA's ROE is +0.02%, compared to DOCS's ROE of +0.17%. Regarding short-term risk, OMDA is less volatile compared to DOCS. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check DOCS's competition here
Heartflow, Inc. Common Stock (NASDAQ: HTFL)
OMDA vs HTFL Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, HTFL has a market cap of 4.1B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while HTFL trades at $47.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas HTFL's P/E ratio is -23.77. In terms of profitability, OMDA's ROE is +0.02%, compared to HTFL's ROE of -0.42%. Regarding short-term risk, OMDA is more volatile compared to HTFL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HTFL's competition here
1Life Healthcare, Inc. (NASDAQ: ONEM)
OMDA vs ONEM Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ONEM has a market cap of 3.4B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ONEM trades at $16.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ONEM's P/E ratio is -7.77. In terms of profitability, OMDA's ROE is +0.02%, compared to ONEM's ROE of -0.24%. Regarding short-term risk, OMDA is more volatile compared to ONEM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ONEM's competition here
Privia Health Group, Inc. (NASDAQ: PRVA)
OMDA vs PRVA Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, PRVA has a market cap of 2.6B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while PRVA trades at $20.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas PRVA's P/E ratio is 99.00. In terms of profitability, OMDA's ROE is +0.02%, compared to PRVA's ROE of +0.00%. Regarding short-term risk, OMDA is more volatile compared to PRVA. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check PRVA's competition here
NextGen Healthcare, Inc. (NASDAQ: NXGN)
OMDA vs NXGN Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, NXGN has a market cap of 1.6B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while NXGN trades at $23.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas NXGN's P/E ratio is -266.00. In terms of profitability, OMDA's ROE is +0.02%, compared to NXGN's ROE of -0.01%. Regarding short-term risk, OMDA is more volatile compared to NXGN. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check NXGN's competition here
Omnicell, Inc. (NASDAQ: OMCL)
OMDA vs OMCL Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, OMCL has a market cap of 1.5B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while OMCL trades at $33.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas OMCL's P/E ratio is 17.32. In terms of profitability, OMDA's ROE is +0.02%, compared to OMCL's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to OMCL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check OMCL's competition here
Agiliti, Inc. (NYSE: AGTI)
OMDA vs AGTI Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, AGTI has a market cap of 1.4B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while AGTI trades at $10.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas AGTI's P/E ratio is -71.79. In terms of profitability, OMDA's ROE is +0.02%, compared to AGTI's ROE of -0.02%. Regarding short-term risk, OMDA is more volatile compared to AGTI. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AGTI's competition here
Certara, Inc. (NASDAQ: CERT)
OMDA vs CERT Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CERT has a market cap of 1.3B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CERT trades at $8.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CERT's P/E ratio is 20.87. In terms of profitability, OMDA's ROE is +0.02%, compared to CERT's ROE of -0.07%. Regarding short-term risk, OMDA is more volatile compared to CERT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CERT's competition here
GoodRx Holdings, Inc. (NASDAQ: GDRX)
OMDA vs GDRX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, GDRX has a market cap of 1.2B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while GDRX trades at $3.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas GDRX's P/E ratio is 11.03. In terms of profitability, OMDA's ROE is +0.02%, compared to GDRX's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to GDRX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check GDRX's competition here
Teladoc Health, Inc. (NYSE: TDOC)
OMDA vs TDOC Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, TDOC has a market cap of 1.2B. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while TDOC trades at $6.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas TDOC's P/E ratio is -6.57. In terms of profitability, OMDA's ROE is +0.02%, compared to TDOC's ROE of -0.13%. Regarding short-term risk, OMDA is more volatile compared to TDOC. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TDOC's competition here
HealthStream, Inc. (NASDAQ: HSTM)
OMDA vs HSTM Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, HSTM has a market cap of 858.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while HSTM trades at $29.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas HSTM's P/E ratio is 40.81. In terms of profitability, OMDA's ROE is +0.02%, compared to HSTM's ROE of +0.06%. Regarding short-term risk, OMDA is more volatile compared to HSTM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HSTM's competition here
CareCloud, Inc. (NASDAQ: CCLDO)
OMDA vs CCLDO Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CCLDO has a market cap of 857.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CCLDO trades at $27.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CCLDO's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CCLDO's ROE of +0.17%. Regarding short-term risk, OMDA is more volatile compared to CCLDO. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CCLDO's competition here
Phreesia, Inc. (NYSE: PHR)
OMDA vs PHR Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, PHR has a market cap of 750.4M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while PHR trades at $12.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas PHR's P/E ratio is 43.36. In terms of profitability, OMDA's ROE is +0.02%, compared to PHR's ROE of +0.03%. Regarding short-term risk, OMDA is less volatile compared to PHR. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check PHR's competition here
SOPHiA GENETICS S.A. (NASDAQ: SOPH)
OMDA vs SOPH Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SOPH has a market cap of 682.9M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SOPH trades at $8.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SOPH's P/E ratio is -7.33. In terms of profitability, OMDA's ROE is +0.02%, compared to SOPH's ROE of -1.37%. Regarding short-term risk, OMDA is less volatile compared to SOPH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SOPH's competition here
Claritev Corporation (NYSE: CTEV)
OMDA vs CTEV Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CTEV has a market cap of 669.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CTEV trades at $39.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CTEV's P/E ratio is -2.31. In terms of profitability, OMDA's ROE is +0.02%, compared to CTEV's ROE of +1.40%. Regarding short-term risk, OMDA is less volatile compared to CTEV. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check CTEV's competition here
MultiPlan Corporation (NYSE: MPLN-WT)
OMDA vs MPLN-WT Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MPLN-WT has a market cap of 625.2M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MPLN-WT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MPLN-WT's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MPLN-WT's ROE of +1.40%. Regarding short-term risk, OMDA is less volatile compared to MPLN-WT. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MPLN-WT's competition here
Accolade, Inc. (NASDAQ: ACCD)
OMDA vs ACCD Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ACCD has a market cap of 575.6M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ACCD trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ACCD's P/E ratio is -3.08. In terms of profitability, OMDA's ROE is +0.02%, compared to ACCD's ROE of -0.22%. Regarding short-term risk, OMDA is more volatile compared to ACCD. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ACCD's competition here
Sharecare, Inc. (NASDAQ: SHCR)
OMDA vs SHCR Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SHCR has a market cap of 531.8M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SHCR trades at $1.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SHCR's P/E ratio is -3.76. In terms of profitability, OMDA's ROE is +0.02%, compared to SHCR's ROE of -0.25%. Regarding short-term risk, OMDA is more volatile compared to SHCR. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SHCR's competition here
Evolent Health, Inc. (NYSE: EVH)
OMDA vs EVH Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, EVH has a market cap of 518M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while EVH trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas EVH's P/E ratio is 35.42. In terms of profitability, OMDA's ROE is +0.02%, compared to EVH's ROE of -0.99%. Regarding short-term risk, OMDA is less volatile compared to EVH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check EVH's competition here
NRC Health (NASDAQ: NRC)
OMDA vs NRC Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, NRC has a market cap of 492.4M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while NRC trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas NRC's P/E ratio is 26.65. In terms of profitability, OMDA's ROE is +0.02%, compared to NRC's ROE of +0.48%. Regarding short-term risk, OMDA is more volatile compared to NRC. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check NRC's competition here
SomaLogic, Inc. (NASDAQ: SLGCW)
OMDA vs SLGCW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SLGCW has a market cap of 396.2M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SLGCW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SLGCW's P/E ratio is -0.16. In terms of profitability, OMDA's ROE is +0.02%, compared to SLGCW's ROE of -0.19%. Regarding short-term risk, OMDA is less volatile compared to SLGCW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SLGCW's competition here
SomaLogic, Inc. (NASDAQ: SLGC)
OMDA vs SLGC Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SLGC has a market cap of 396.2M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SLGC trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SLGC's P/E ratio is -3.04. In terms of profitability, OMDA's ROE is +0.02%, compared to SLGC's ROE of -0.19%. Regarding short-term risk, OMDA is less volatile compared to SLGC. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SLGC's competition here
TruBridge, Inc. (NASDAQ: TBRG)
OMDA vs TBRG Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, TBRG has a market cap of 393.6M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while TBRG trades at $26.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas TBRG's P/E ratio is 9.37. In terms of profitability, OMDA's ROE is +0.02%, compared to TBRG's ROE of +0.02%. Regarding short-term risk, OMDA is more volatile compared to TBRG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TBRG's competition here
MultiPlan Corporation (NYSE: MPLN)
OMDA vs MPLN Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MPLN has a market cap of 375M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MPLN trades at $23.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MPLN's P/E ratio is -0.23. In terms of profitability, OMDA's ROE is +0.02%, compared to MPLN's ROE of +1.40%. Regarding short-term risk, OMDA is less volatile compared to MPLN. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MPLN's competition here
So-Young International Inc. (NASDAQ: SY)
OMDA vs SY Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SY has a market cap of 314.9M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SY trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SY's P/E ratio is -7.27. In terms of profitability, OMDA's ROE is +0.02%, compared to SY's ROE of -0.16%. Regarding short-term risk, OMDA is less volatile compared to SY. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SY's competition here
Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC)
OMDA vs TRHC Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, TRHC has a market cap of 284M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while TRHC trades at $10.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas TRHC's P/E ratio is -4.27. In terms of profitability, OMDA's ROE is +0.02%, compared to TRHC's ROE of +121.31%. Regarding short-term risk, OMDA is more volatile compared to TRHC. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check TRHC's competition here
Sema4 Holdings Corp. (NASDAQ: SMFR)
OMDA vs SMFR Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SMFR has a market cap of 246.4M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SMFR trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SMFR's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to SMFR's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to SMFR. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SMFR's competition here
Spok Holdings, Inc. (NASDAQ: SPOK)
OMDA vs SPOK Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SPOK has a market cap of 222.4M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SPOK trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SPOK's P/E ratio is 17.75. In terms of profitability, OMDA's ROE is +0.02%, compared to SPOK's ROE of +0.09%. Regarding short-term risk, OMDA is more volatile compared to SPOK. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SPOK's competition here
American Well Corporation (NYSE: AMWL)
OMDA vs AMWL Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, AMWL has a market cap of 202.2M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while AMWL trades at $11.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas AMWL's P/E ratio is -2.69. In terms of profitability, OMDA's ROE is +0.02%, compared to AMWL's ROE of -0.33%. Regarding short-term risk, OMDA is more volatile compared to AMWL. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AMWL's competition here
LifeMD, Inc. (NASDAQ: LFMDP)
OMDA vs LFMDP Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, LFMDP has a market cap of 156.9M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while LFMDP trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas LFMDP's P/E ratio is -709.24. In terms of profitability, OMDA's ROE is +0.02%, compared to LFMDP's ROE of -1.79%. Regarding short-term risk, OMDA is more volatile compared to LFMDP. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LFMDP's competition here
LifeMD, Inc. (NASDAQ: LFMD)
OMDA vs LFMD Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, LFMD has a market cap of 151.9M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while LFMD trades at $3.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas LFMD's P/E ratio is -6.28. In terms of profitability, OMDA's ROE is +0.02%, compared to LFMD's ROE of -1.79%. Regarding short-term risk, OMDA is less volatile compared to LFMD. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check LFMD's competition here
OptimizeRx Corp. (NASDAQ: OPRX)
OMDA vs OPRX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, OPRX has a market cap of 149.2M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while OPRX trades at $7.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas OPRX's P/E ratio is 7.29. In terms of profitability, OMDA's ROE is +0.02%, compared to OPRX's ROE of +0.04%. Regarding short-term risk, OMDA is less volatile compared to OPRX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check OPRX's competition here
Computer Programs and Systems, Inc. (NASDAQ: CPSI)
OMDA vs CPSI Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CPSI has a market cap of 133.7M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CPSI trades at $9.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CPSI's P/E ratio is -183.80. In terms of profitability, OMDA's ROE is +0.02%, compared to CPSI's ROE of +0.02%. Regarding short-term risk, OMDA is less volatile compared to CPSI. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check CPSI's competition here
Health Catalyst, Inc. (NASDAQ: HCAT)
OMDA vs HCAT Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, HCAT has a market cap of 117.5M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while HCAT trades at $1.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas HCAT's P/E ratio is 7.95. In terms of profitability, OMDA's ROE is +0.02%, compared to HCAT's ROE of -1.30%. Regarding short-term risk, OMDA is more volatile compared to HCAT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check HCAT's competition here
Augmedix, Inc. (NASDAQ: AUGX)
OMDA vs AUGX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, AUGX has a market cap of 115.9M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while AUGX trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas AUGX's P/E ratio is -4.99. In terms of profitability, OMDA's ROE is +0.02%, compared to AUGX's ROE of -1.55%. Regarding short-term risk, OMDA is more volatile compared to AUGX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AUGX's competition here
CareCloud, Inc. (NASDAQ: CCLD)
OMDA vs CCLD Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CCLD has a market cap of 105.8M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CCLD trades at $2.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CCLD's P/E ratio is 9.58. In terms of profitability, OMDA's ROE is +0.02%, compared to CCLD's ROE of +0.17%. Regarding short-term risk, OMDA is less volatile compared to CCLD. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check CCLD's competition here
SCWorx Corp. (NASDAQ: WORX)
OMDA vs WORX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, WORX has a market cap of 88M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while WORX trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas WORX's P/E ratio is -6.40. In terms of profitability, OMDA's ROE is +0.02%, compared to WORX's ROE of -0.35%. Regarding short-term risk, OMDA is less volatile compared to WORX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check WORX's competition here
Definitive Healthcare Corp. (NASDAQ: DH)
OMDA vs DH Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, DH has a market cap of 84.7M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while DH trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas DH's P/E ratio is 3.09. In terms of profitability, OMDA's ROE is +0.02%, compared to DH's ROE of -0.79%. Regarding short-term risk, OMDA is less volatile compared to DH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check DH's competition here
Forian Inc. (NASDAQ: FORA)
OMDA vs FORA Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, FORA has a market cap of 67.8M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while FORA trades at $2.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas FORA's P/E ratio is -24.11. In terms of profitability, OMDA's ROE is +0.02%, compared to FORA's ROE of -0.17%. Regarding short-term risk, OMDA is more volatile compared to FORA. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check FORA's competition here
CareCloud, Inc. (NASDAQ: CCLDP)
OMDA vs CCLDP Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CCLDP has a market cap of 59.9M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CCLDP trades at $19.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CCLDP's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CCLDP's ROE of +0.17%. Regarding short-term risk, OMDA is more volatile compared to CCLDP. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CCLDP's competition here
Science 37 Holdings, Inc. (NASDAQ: SNCE)
OMDA vs SNCE Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SNCE has a market cap of 34.7M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SNCE trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SNCE's P/E ratio is -0.27. In terms of profitability, OMDA's ROE is +0.02%, compared to SNCE's ROE of -0.47%. Regarding short-term risk, OMDA is more volatile compared to SNCE. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SNCE's competition here
Akili, Inc. (NASDAQ: AKLI)
OMDA vs AKLI Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, AKLI has a market cap of 34.1M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while AKLI trades at $0.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas AKLI's P/E ratio is -0.71. In terms of profitability, OMDA's ROE is +0.02%, compared to AKLI's ROE of -0.70%. Regarding short-term risk, OMDA is more volatile compared to AKLI. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AKLI's competition here
SHL Telemedicine Ltd. (NASDAQ: SHLT)
OMDA vs SHLT Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SHLT has a market cap of 33.6M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SHLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SHLT's P/E ratio is -3.87. In terms of profitability, OMDA's ROE is +0.02%, compared to SHLT's ROE of -0.50%. Regarding short-term risk, OMDA is more volatile compared to SHLT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check SHLT's competition here
OneMedNet Corporation (NASDAQ: ONMD)
OMDA vs ONMD Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ONMD has a market cap of 33M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ONMD trades at $0.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ONMD's P/E ratio is -3.62. In terms of profitability, OMDA's ROE is +0.02%, compared to ONMD's ROE of +2.35%. Regarding short-term risk, OMDA is less volatile compared to ONMD. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ONMD's competition here
Sharecare, Inc. (NASDAQ: SHCRW)
OMDA vs SHCRW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SHCRW has a market cap of 32.5M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SHCRW trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SHCRW's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to SHCRW's ROE of -0.25%. Regarding short-term risk, OMDA is less volatile compared to SHCRW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SHCRW's competition here
OneMedNet Corporation (NASDAQ: ONMDW)
OMDA vs ONMDW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ONMDW has a market cap of 31.1M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ONMDW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ONMDW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to ONMDW's ROE of +2.35%. Regarding short-term risk, OMDA is less volatile compared to ONMDW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ONMDW's competition here
Streamline Health Solutions, Inc. (NASDAQ: STRM)
OMDA vs STRM Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, STRM has a market cap of 23.2M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while STRM trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas STRM's P/E ratio is -2.40. In terms of profitability, OMDA's ROE is +0.02%, compared to STRM's ROE of -0.65%. Regarding short-term risk, OMDA is more volatile compared to STRM. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check STRM's competition here
Renalytix Plc (NASDAQ: RNLX)
OMDA vs RNLX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, RNLX has a market cap of 22.5M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while RNLX trades at $0.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas RNLX's P/E ratio is -0.33. In terms of profitability, OMDA's ROE is +0.02%, compared to RNLX's ROE of -6.31%. Regarding short-term risk, OMDA is less volatile compared to RNLX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check RNLX's competition here
MSP Recovery, Inc. (NASDAQ: LIFW)
OMDA vs LIFW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, LIFW has a market cap of 22.4M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while LIFW trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas LIFW's P/E ratio is -0.02. In terms of profitability, OMDA's ROE is +0.02%, compared to LIFW's ROE of +1.56%. Regarding short-term risk, OMDA is more volatile compared to LIFW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LIFW's competition here
Babylon Holdings Limited (NYSE: BBLN)
OMDA vs BBLN Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, BBLN has a market cap of 14.1M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while BBLN trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas BBLN's P/E ratio is -0.04. In terms of profitability, OMDA's ROE is +0.02%, compared to BBLN's ROE of +4.89%. Regarding short-term risk, OMDA is less volatile compared to BBLN. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check BBLN's competition here
Bullfrog AI Holdings, Inc. Common Stock (NASDAQ: BFRG)
OMDA vs BFRG Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, BFRG has a market cap of 10.1M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while BFRG trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas BFRG's P/E ratio is -1.18. In terms of profitability, OMDA's ROE is +0.02%, compared to BFRG's ROE of -1.50%. Regarding short-term risk, OMDA is less volatile compared to BFRG. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check BFRG's competition here
ETAO International Co., Ltd. (NASDAQ: ETAO)
OMDA vs ETAO Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ETAO has a market cap of 9.8M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ETAO trades at $1.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ETAO's P/E ratio is -0.01. In terms of profitability, OMDA's ROE is +0.02%, compared to ETAO's ROE of -13.69%. Regarding short-term risk, OMDA is less volatile compared to ETAO. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ETAO's competition here
Mangoceuticals, Inc. (NASDAQ: MGRX)
OMDA vs MGRX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MGRX has a market cap of 6.8M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MGRX trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MGRX's P/E ratio is -0.30. In terms of profitability, OMDA's ROE is +0.02%, compared to MGRX's ROE of -1.06%. Regarding short-term risk, OMDA is less volatile compared to MGRX. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MGRX's competition here
UpHealth, Inc. (NYSE: UPH-WT)
OMDA vs UPH-WT Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, UPH-WT has a market cap of 5.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while UPH-WT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas UPH-WT's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to UPH-WT's ROE of -1.05%. Regarding short-term risk, OMDA is less volatile compared to UPH-WT. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check UPH-WT's competition here
UpHealth, Inc. (NYSE: UPH)
OMDA vs UPH Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, UPH has a market cap of 5.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while UPH trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas UPH's P/E ratio is -0.07. In terms of profitability, OMDA's ROE is +0.02%, compared to UPH's ROE of -1.05%. Regarding short-term risk, OMDA is less volatile compared to UPH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check UPH's competition here
Pear Therapeutics, Inc. (NASDAQ: PEAR)
OMDA vs PEAR Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, PEAR has a market cap of 4.1M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while PEAR trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas PEAR's P/E ratio is -0.08. In terms of profitability, OMDA's ROE is +0.02%, compared to PEAR's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to PEAR. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check PEAR's competition here
Pear Therapeutics, Inc. (NASDAQ: PEARW)
OMDA vs PEARW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, PEARW has a market cap of 4.1M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while PEARW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas PEARW's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to PEARW's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to PEARW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check PEARW's competition here
Ontrak, Inc. (NASDAQ: OTRK)
OMDA vs OTRK Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, OTRK has a market cap of 2.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while OTRK trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas OTRK's P/E ratio is -0.02. In terms of profitability, OMDA's ROE is +0.02%, compared to OTRK's ROE of -2.11%. Regarding short-term risk, OMDA is more volatile compared to OTRK. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check OTRK's competition here
CareMax, Inc. (NASDAQ: CMAX)
OMDA vs CMAX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CMAX has a market cap of 1.6M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CMAX trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CMAX's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to CMAX's ROE of -2.01%. Regarding short-term risk, OMDA is more volatile compared to CMAX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CMAX's competition here
Bullfrog AI Holdings, Inc. Warrants (NASDAQ: BFRGW)
OMDA vs BFRGW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, BFRGW has a market cap of 1.4M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while BFRGW trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas BFRGW's P/E ratio is -0.92. In terms of profitability, OMDA's ROE is +0.02%, compared to BFRGW's ROE of -1.50%. Regarding short-term risk, OMDA is more volatile compared to BFRGW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check BFRGW's competition here
Aclarion, Inc. (NASDAQ: ACON)
OMDA vs ACON Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ACON has a market cap of 1.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ACON trades at $2.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ACON's P/E ratio is -0.27. In terms of profitability, OMDA's ROE is +0.02%, compared to ACON's ROE of -0.59%. Regarding short-term risk, OMDA is less volatile compared to ACON. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ACON's competition here
MSP Recovery, Inc. (NASDAQ: LIFWZ)
OMDA vs LIFWZ Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, LIFWZ has a market cap of 1.3M. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while LIFWZ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas LIFWZ's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to LIFWZ's ROE of +1.56%. Regarding short-term risk, OMDA is more volatile compared to LIFWZ. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LIFWZ's competition here
Healthcare Triangle, Inc. (NASDAQ: HCTI)
OMDA vs HCTI Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, HCTI has a market cap of 975.4K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while HCTI trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas HCTI's P/E ratio is -0.11. In terms of profitability, OMDA's ROE is +0.02%, compared to HCTI's ROE of -0.56%. Regarding short-term risk, OMDA is less volatile compared to HCTI. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check HCTI's competition here
VSee Health, Inc. (NASDAQ: VSEEW)
OMDA vs VSEEW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, VSEEW has a market cap of 560.3K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while VSEEW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas VSEEW's P/E ratio is -0.04. In terms of profitability, OMDA's ROE is +0.02%, compared to VSEEW's ROE of -4.01%. Regarding short-term risk, OMDA is less volatile compared to VSEEW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check VSEEW's competition here
MSP Recovery, Inc. (NASDAQ: MSPRZ)
OMDA vs MSPRZ Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MSPRZ has a market cap of 550.4K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MSPRZ trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MSPRZ's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MSPRZ's ROE of +1.56%. Regarding short-term risk, OMDA is less volatile compared to MSPRZ. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MSPRZ's competition here
VSee Health, Inc. (NASDAQ: VSEE)
OMDA vs VSEE Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, VSEE has a market cap of 245.6K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while VSEE trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas VSEE's P/E ratio is -0.03. In terms of profitability, OMDA's ROE is +0.02%, compared to VSEE's ROE of -4.01%. Regarding short-term risk, OMDA is less volatile compared to VSEE. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check VSEE's competition here
Akerna Corp. (NASDAQ: KERNW)
OMDA vs KERNW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, KERNW has a market cap of 162.3K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while KERNW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas KERNW's P/E ratio is -0.00. In terms of profitability, OMDA's ROE is +0.02%, compared to KERNW's ROE of -0.20%. Regarding short-term risk, OMDA is less volatile compared to KERNW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check KERNW's competition here
Akerna Corp. (NASDAQ: KERN)
OMDA vs KERN Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, KERN has a market cap of 162.3K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while KERN trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas KERN's P/E ratio is -0.01. In terms of profitability, OMDA's ROE is +0.02%, compared to KERN's ROE of -0.20%. Regarding short-term risk, OMDA is less volatile compared to KERN. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check KERN's competition here
MSP Recovery, Inc. (NASDAQ: LIFWW)
OMDA vs LIFWW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, LIFWW has a market cap of 60.1K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while LIFWW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas LIFWW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to LIFWW's ROE of +1.56%. Regarding short-term risk, OMDA is more volatile compared to LIFWW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check LIFWW's competition here
CareMax, Inc. (NASDAQ: CMAXW)
OMDA vs CMAXW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CMAXW has a market cap of 36.4K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CMAXW trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CMAXW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CMAXW's ROE of -2.01%. Regarding short-term risk, OMDA is more volatile compared to CMAXW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CMAXW's competition here
Zhongchao Inc. (NASDAQ: ZCMD)
OMDA vs ZCMD Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ZCMD has a market cap of 32.1K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ZCMD trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ZCMD's P/E ratio is -0.03. In terms of profitability, OMDA's ROE is +0.02%, compared to ZCMD's ROE of -0.32%. Regarding short-term risk, OMDA is less volatile compared to ZCMD. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check ZCMD's competition here
Aclarion, Inc. (NASDAQ: ACONW)
OMDA vs ACONW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, ACONW has a market cap of 13.6K. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while ACONW trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas ACONW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to ACONW's ROE of -0.59%. Regarding short-term risk, OMDA is more volatile compared to ACONW. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check ACONW's competition here
Affymetrix, Inc. (NASDAQ: AFFX)
OMDA vs AFFX Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, AFFX has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while AFFX trades at $14.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas AFFX's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to AFFX's ROE of +0.03%. Regarding short-term risk, OMDA is more volatile compared to AFFX. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check AFFX's competition here
CareCloud, Inc. (NASDAQ: MTBCP)
OMDA vs MTBCP Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MTBCP has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MTBCP trades at $26.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MTBCP's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MTBCP's ROE of +0.17%. Regarding short-term risk, OMDA is more volatile compared to MTBCP. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check MTBCP's competition here
Cerner Corporation (NASDAQ: CERN)
OMDA vs CERN Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CERN has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CERN trades at $94.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CERN's P/E ratio is 55.84. In terms of profitability, OMDA's ROE is +0.02%, compared to CERN's ROE of +0.14%. Regarding short-term risk, OMDA is more volatile compared to CERN. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CERN's competition here
CareCloud, Inc. (NASDAQ: MTBCO)
OMDA vs MTBCO Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MTBCO has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MTBCO trades at $25.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MTBCO's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MTBCO's ROE of +0.17%. Regarding short-term risk, OMDA is more volatile compared to MTBCO. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check MTBCO's competition here
Change Healthcare Inc. (NASDAQ: CHNG)
OMDA vs CHNG Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CHNG has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CHNG trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CHNG's P/E ratio is -152.72. In terms of profitability, OMDA's ROE is +0.02%, compared to CHNG's ROE of -0.05%. Regarding short-term risk, OMDA is more volatile compared to CHNG. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CHNG's competition here
MSP Recovery, Inc. (NASDAQ: MSPRV)
OMDA vs MSPRV Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MSPRV has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MSPRV trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MSPRV's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MSPRV's ROE of N/A. Regarding short-term risk, OMDA is less volatile compared to MSPRV. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MSPRV's competition here
Change Healthcare Inc. (NASDAQ: CHNGU)
OMDA vs CHNGU Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CHNGU has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CHNGU trades at $73.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CHNGU's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to CHNGU's ROE of -0.05%. Regarding short-term risk, OMDA is more volatile compared to CHNGU. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CHNGU's competition here
Alkuri Global Acquisition Corp. (NASDAQ: KURIU)
OMDA vs KURIU Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, KURIU has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while KURIU trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas KURIU's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to KURIU's ROE of +1.06%. Regarding short-term risk, OMDA is less volatile compared to KURIU. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check KURIU's competition here
Sema4 Holdings Corp. (NASDAQ: SMFRW)
OMDA vs SMFRW Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, SMFRW has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while SMFRW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas SMFRW's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to SMFRW's ROE of -0.39%. Regarding short-term risk, OMDA is less volatile compared to SMFRW. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check SMFRW's competition here
IMS Health Holdings, Inc. (NYSE: IMS)
OMDA vs IMS Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, IMS has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while IMS trades at $31.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas IMS's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to IMS's ROE of +0.27%. Regarding short-term risk, OMDA is more volatile compared to IMS. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check IMS's competition here
NantHealth, Inc. (NASDAQ: NH)
OMDA vs NH Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, NH has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while NH trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas NH's P/E ratio is -0.12. In terms of profitability, OMDA's ROE is +0.02%, compared to NH's ROE of +0.35%. Regarding short-term risk, OMDA is less volatile compared to NH. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check NH's competition here
Castlight Health, Inc. (NYSE: CSLT)
OMDA vs CSLT Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CSLT has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CSLT trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CSLT's P/E ratio is -37.27. In terms of profitability, OMDA's ROE is +0.02%, compared to CSLT's ROE of -0.42%. Regarding short-term risk, OMDA is more volatile compared to CSLT. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CSLT's competition here
Nava Health MD, LLC (NASDAQ: NAVA)
OMDA vs NAVA Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, NAVA has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while NAVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas NAVA's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to NAVA's ROE of +0.15%. Regarding short-term risk, OMDA is not fully comparable compared to NAVA. This indicates unavailable risk data in terms of short-term price fluctuations for OMDA.Check NAVA's competition here
Convey Health Solutions Holdings, Inc. (NYSE: CNVY)
OMDA vs CNVY Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, CNVY has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while CNVY trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas CNVY's P/E ratio is -71.50. In terms of profitability, OMDA's ROE is +0.02%, compared to CNVY's ROE of -0.02%. Regarding short-term risk, OMDA is more volatile compared to CNVY. This indicates higher risk in terms of short-term price fluctuations for OMDA.Check CNVY's competition here
CareCloud, Inc. (NASDAQ: MTBC)
OMDA vs MTBC Comparison September 2026
Omada Health (NASDAQ: OMDA) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, OMDA stands at 1.4B. In comparison, MTBC has a market cap of 0. Regarding current trading prices, OMDA is priced at $23.69 on the NASDAQ, while MTBC trades at $3.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
OMDA currently has a P/E ratio of 338.43, whereas MTBC's P/E ratio is N/A. In terms of profitability, OMDA's ROE is +0.02%, compared to MTBC's ROE of +0.19%. Regarding short-term risk, OMDA is less volatile compared to MTBC. This indicates lower risk in terms of short-term price fluctuations for OMDA.Check MTBC's competition here